Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
6-Arylpyrazine-2-carboxamides : a new core for Trypanosoma brucei inhibitors
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 3439763
Author(s) Rahmani, Raphaël; Ban, Kung; Jones, Amy J.; Ferrins, Lori; Ganame, Danny; Sykes, Melissa L.; Avery, Vicky M.; White, Karen L.; Ryan, Eileen; Kaiser, Marcel; Charman, Susan A.; Baell, Jonathan B.
Author(s) at UniBasel Kaiser, Marcel
Year 2015
Title 6-Arylpyrazine-2-carboxamides : a new core for Trypanosoma brucei inhibitors
Journal Journal of medicinal chemistry
Volume 58
Number 17
Pages / Article-Number 6753-65
Abstract From a whole-organism high throughput screen of approximately 87000 compounds against Trypanosoma brucei brucei, we recently identified eight new unique compounds for the treatment of human African trypanosomiasis. In an effort to understand the structure-activity relationships around these compounds, we report for the first time our results on a new class of trypanocides, the pyrazine carboxamides. Attracted by the low molecular weight (270 g·mol(-1)) of our starting hit (9) and its potency (0.49 μM), the SAR around the core was explored, leading to compounds having an EC50 as low as 25 nM against T. b. brucei and being more than 1500 times less toxic against mammalian L6 and HEK293 cell lines. The most potent compounds in the series were exquisitely selective for T. brucei over a panel of other protozoan parasites, showing an excellent correlation with the human infective parasite Trypanosoma brucei rhodesiense, the most potent compound (65) having an EC50 of 24 nM. The compounds are highly drug-like and are able to penetrate the CNS, their only limitation currently being their rate of microsomal metabolism. To that effect, efforts to identify potential metabolites of selected compounds are also reported.
Publisher American Chemical Society
ISSN/ISBN 0022-2623
edoc-URL http://edoc.unibas.ch/42085/
Full Text on edoc No
Digital Object Identifier DOI 10.1021/acs.jmedchem.5b00438
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/26247439
ISI-Number WOS:000361254600004
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.330 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
29/03/2024